🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Prestige Biologics Co., Ltd. (KOSDAQ:334970)
South Korea flag South Korea · Delayed Price · Currency is KRW
1,057.00
-42.00 (-3.82%)
At close: Nov 20, 2026

Prestige Biologics Market Cap

Prestige Biologics has a market cap or net worth of 82.18 billion as of November 20, 2026. It is the 28,046th most valuable company in the world and the 1,312th biggest in South Korea. Its market cap has decreased by 63.68% in one year.

Market Cap
82.18B
Enterprise Value
176.55B
Revenue
26.67B
Global Rank
Country Rank
#1,312 South Korea
PE Ratio
n/a

Chart

Chart

Since March 11, 2021, Prestige Biologics's market cap has decreased from 613.27B to 82.18B, a decrease of -86.60%. That is a compound annual growth rate of -29.72%.

History

DateMarket Cap% Change
Nov 20, 202682.18B-65.17%
Dec 30, 2025235.98B-40.12%
Dec 30, 2024394.06B46.25%
Dec 28, 2023269.45B46.01%
Dec 29, 2022184.55B-59.28%
Dec 30, 2021453.18B-26.10%
Mar 11, 2021 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Related Stocks

CompanyMarket Cap
Kanaph Therapeutics111.86B
Ensol Biosciences105.81B
TiumBio105.44B
Cell Biotech94.31B
ViGenCell85.99B
Choong Ang Vaccine Laboratory82.76B
EyeGene76.08B
CTCBIO66.11B
Market Cap Rankings